Newsletter | 01 February 2003 Access News 8, Focus on Access Three Years On, February 2003 HIV/AIDS RESEARCH AND DEVELOPMENT TROPICAL & NEGLECTED DISEASES VACCINES The Access Campaign three years on is addressed in this issue of AccessNews, as well as the fear of another meningitis epidemic, Roche's failing of HIV patients, fighting against neglected diseases, no agreements at Doha and HIV positive children. Read, watch, share Filter by - Any -BlogEventsFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechStatementTechnical briefTopic overviewVideo Press release | 12 July 2004 HIV/AIDS Intellectual property and trade MSF reports on progress and challenges of expanding aids treatment programs Opinion article | 03 July 2004 HIV/AIDS Lancet commentary: Generic antiretroviral drugs—will they be the answer to HIV in the developing world? Press release | 02 July 2004 HIV/AIDS Intellectual property and trade An advance for HIV/AIDS treatment access in the developing countries Letter | 24 June 2004 HIV/AIDS New England Journal of Medecine: MSF letter to the Editor 'HIV Drug Resistance' Press release | 18 May 2004 HIV/AIDS Intellectual property and trade MSF statement on US government announcement of new procedure for reviewing the safety and efficacy of fixed-dose combinations and co-blisters of antiretrovirals Speech | 30 March 2004 HIV/AIDS MSF statement by Ellen ‘t Hoen at the Conference on Fixed Dose Combination (FDC) Drug Products 3 min Letter | 25 March 2004 HIV/AIDS MSF open letter to US organisers of the conference on FDC drug products (Gabarone, Botswana on March 29-30, 2004) Letter | 08 March 2004 HIV/AIDS Merck response to MSF letter of 26 February 2004 7 min Load More
Press release | 12 July 2004 HIV/AIDS Intellectual property and trade MSF reports on progress and challenges of expanding aids treatment programs
Opinion article | 03 July 2004 HIV/AIDS Lancet commentary: Generic antiretroviral drugs—will they be the answer to HIV in the developing world?
Press release | 02 July 2004 HIV/AIDS Intellectual property and trade An advance for HIV/AIDS treatment access in the developing countries
Letter | 24 June 2004 HIV/AIDS New England Journal of Medecine: MSF letter to the Editor 'HIV Drug Resistance'
Press release | 18 May 2004 HIV/AIDS Intellectual property and trade MSF statement on US government announcement of new procedure for reviewing the safety and efficacy of fixed-dose combinations and co-blisters of antiretrovirals
Speech | 30 March 2004 HIV/AIDS MSF statement by Ellen ‘t Hoen at the Conference on Fixed Dose Combination (FDC) Drug Products 3 min
Letter | 25 March 2004 HIV/AIDS MSF open letter to US organisers of the conference on FDC drug products (Gabarone, Botswana on March 29-30, 2004)
